“…It has been widely shown that, compared to pharmacological treatment, STN-DBS is more effective in improving motor functions and the quality of life of patients with advanced PD, in both short- and long-term follow-up [ 1 , 2 , 3 ]. Particularly, in the long-term, STN-DBS allows a stable improvement of motor complications, tremor and rigidity but with a less relevant effect on axial symptoms (e.g., gait and balance symptoms, speech and swallowing troubles) and cognitive decline [ 4 , 5 ]. The most common surgical complications of STN-DBS include intracranial haemorrhages, electrodes malposition, infection, seizures and ischemic strokes [ 6 , 7 ].…”